Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of Single Dose of EDP167 Injection in Healthy Volunteers and Subjects With Mild Dyslipidemia

NCT07412080 is registered in ClinicalTrials.gov with Eddingpharm (Zhuhai) Co., Ltd. as lead sponsor.

NCT NCT07412080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07412080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of Single Dose of EDP167 Injection in Healthy Volunteers and Subjects With Mild Dyslipidemia
Lead sponsor
Eddingpharm (Zhuhai) Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
July 1, 2025
Completion date
December 12, 2025
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult male and female volunteers, mild dyslipidemia